OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Checkpoint Inhibitors in Melanoma Patients with Underlying Autoimmune Disease
Hilary Dietz, Sophia C. Weinmann, April K.S. Salama
Cancer Management and Research (2021) Vol. Volume 13, pp. 8199-8208
Open Access | Times Cited: 15
Hilary Dietz, Sophia C. Weinmann, April K.S. Salama
Cancer Management and Research (2021) Vol. Volume 13, pp. 8199-8208
Open Access | Times Cited: 15
Showing 15 citing articles:
Engineering multifunctional dynamic hydrogel for biomedical and tissue regenerative applications
Bohan Yin, Monika Gosecka, Mahdi Bodaghi, et al.
Chemical Engineering Journal (2024) Vol. 487, pp. 150403-150403
Open Access | Times Cited: 29
Bohan Yin, Monika Gosecka, Mahdi Bodaghi, et al.
Chemical Engineering Journal (2024) Vol. 487, pp. 150403-150403
Open Access | Times Cited: 29
PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases
Ke Zhang, Xiangyi Kong, Yuan Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Ke Zhang, Xiangyi Kong, Yuan Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing autoimmune disease
María A. López-Olivo, Johncy John Kachira, Noha Abdel‐Wahab, et al.
European Journal of Cancer (2024) Vol. 207, pp. 114148-114148
Closed Access | Times Cited: 4
María A. López-Olivo, Johncy John Kachira, Noha Abdel‐Wahab, et al.
European Journal of Cancer (2024) Vol. 207, pp. 114148-114148
Closed Access | Times Cited: 4
Monoclonal antibodies as adjuvant therapies for resected melanoma
Islam Eljilany, Julita García, Basem T. Jamal, et al.
Expert Opinion on Biological Therapy (2025), pp. 1-14
Closed Access
Islam Eljilany, Julita García, Basem T. Jamal, et al.
Expert Opinion on Biological Therapy (2025), pp. 1-14
Closed Access
Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy
Bahareh Farasati Far, Dorsa Rabie, Parisa Hemati, et al.
Livers (2023) Vol. 3, Iss. 1, pp. 121-160
Open Access | Times Cited: 9
Bahareh Farasati Far, Dorsa Rabie, Parisa Hemati, et al.
Livers (2023) Vol. 3, Iss. 1, pp. 121-160
Open Access | Times Cited: 9
Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer
YaLing Liu, Dan Li, Yong Chen, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5
YaLing Liu, Dan Li, Yong Chen, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Association between Immunosuppressive Therapy Utilized in the Treatment of Autoimmune Disease or Transplant and Cancer Progression
Amanda Reyes, Atish Mohanty, Rebecca Pharaon, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 99-99
Open Access | Times Cited: 8
Amanda Reyes, Atish Mohanty, Rebecca Pharaon, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 99-99
Open Access | Times Cited: 8
Nivolumab combination therapy as first-line treatments for unresectable, advanced or metastatic esophageal squamous cell carcinoma
Jane E. Rogers, Kohei Yamashita, Matheus Sewastjanow‐Silva, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 6, pp. 565-571
Closed Access | Times Cited: 4
Jane E. Rogers, Kohei Yamashita, Matheus Sewastjanow‐Silva, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 6, pp. 565-571
Closed Access | Times Cited: 4
Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Psoriasis: A Systematic Review and Meta-Analysis of Observational Studies
Yixuan Yu, Yang Zhou, Xu Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Yixuan Yu, Yang Zhou, Xu Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Molecular Docking and Intracellular Translocation of Extracellular Vesicles for Efficient Drug Delivery
Yasunari Matsuzaka, Ryu Yashiro
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12971-12971
Open Access | Times Cited: 5
Yasunari Matsuzaka, Ryu Yashiro
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12971-12971
Open Access | Times Cited: 5
Dermatological Autoimmune Considerations of Immune Checkpoint Therapy
Lauren S. Fane, Jimmy T. Efird, Charulata Jindal, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2339-2339
Open Access | Times Cited: 1
Lauren S. Fane, Jimmy T. Efird, Charulata Jindal, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2339-2339
Open Access | Times Cited: 1
Additional file 5 of Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer
YaLing Liu, Dan Li, Yong Chen, et al.
Figshare (2023)
Open Access
YaLing Liu, Dan Li, Yong Chen, et al.
Figshare (2023)
Open Access
Additional file 2 of Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer
YaLing Liu, Dan Li, Yong Chen, et al.
Figshare (2023)
Open Access
YaLing Liu, Dan Li, Yong Chen, et al.
Figshare (2023)
Open Access
Additional file 3 of Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer
YaLing Liu, Dan Li, Yong Chen, et al.
Figshare (2023)
Open Access
YaLing Liu, Dan Li, Yong Chen, et al.
Figshare (2023)
Open Access
Additional file 4 of Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer
YaLing Liu, Dan Li, Yong Chen, et al.
Figshare (2023)
Open Access
YaLing Liu, Dan Li, Yong Chen, et al.
Figshare (2023)
Open Access
